Serum levels and in situ expression of TNF-α and TNF-α binding proteins in inflammatory liver diseases

Cytokine

Volumn 8, Issue 11, 1996, Pages 864-872

  Spengler, Ulrich ^a,e   Zachoval, Reinhart ^b   Gallati, Harald ^d   Jung, Maria Christina ^b,c   Hoffmann, Robert ^b,c   Riethmüller, Gert ^c   Pape, Gerd ^b,c  

^a UNIVERSITY OF BONN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Alcoholic hepatitis; Interferon therapy; Tumour necrosis factor; Tumour necrosis factor binding protein; Viral hepatitis

Indexed keywords

ALPHA INTERFERON; AMINOTRANSFERASE; RECOMBINANT ALPHA2B INTERFERON; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ALCOHOL LIVER DISEASE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME IMMUNOASSAY; HEPATITIS; HEPATITIS B; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOPEROXIDASE STAINING; LIVER BIOPSY; LIVER CELL; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS HEPATITIS;

EID: 0030295358     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0115     Document Type: Article

References (52)

1. 1. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey III TJ, Zentella A, Albert JD, Shires GT, Cerami A. (1986) Shock and tissue injury induced by recombinant human cachectin, Science 234:470-474.
2. 2. Fey GH, Gauldie J (1990) The acute phase response of the liver in inflammation. In: Popper H Schaffner F, eds. Progress in Liver Diseases IX, Philadelphia: W.B. Saunders, 89-116.
3. 3. Perlmutter DH, Dinarello CA, Punsal PI, Colton HR (1986) Cachectin/Tumour necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 78:1349-1354.
4. 4. Muto Y, Nouri-Aria KT, Meager A, Alexander GJM, Eddleston ALWF, Williams R (1988) Enhanced tumour necrosis factor and interleukin-1β in fulminant hepatic failure. Lancet, 2:72-74.
5. 5. Tilg H, Vogel W, Aulitzky WE, Herold M, Koenigsrainer A, Margreiter R, Huber C, (1990) Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation. Transplantation 49:1074-1080.
6. 6. Sheron N, Lau JYN, Daniels H, Goka J, Eddleston ALWF, Alexander GJM, Williams R (1991) Increased production of tumour necrosis factor alpha in hepatitis B. J Hepatol, 12:241-245.
7. 7. Lau JYN, Sheron N, Nouri-Aria KT, Alexander GJM, Williams R. (1991) Increased tumour necrosis factor-α receptor number in chronic hepatitis B virus infection. Hepatology 4:44-50.
8. 8. McClain CJ, Cohen DA. (1989) Increased tumour necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9:349-351.
9. 9. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H. (1990) Identification of two types of tumour necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127-3131.
10. 10. Hohmann HP, Remy R. Brockhaus M, van Loon APGM (1989) Two different cell types have different major receptors for human tumour necrosis factor (TNF-α). J Biol Chem 264:14927-14934.
11. 11. Schoenfeld HJ, Poeschl B, Frey JR, Loetscher HR, Hunziker W, Lustig A, Zulauf M (1991) Efficient purification of recombinant human tumour necrosis factor beta from E. coli yields biologically active protein with a trimeric structure that binds to both TNF receptors. J Biol Chem 266:3863-3869.
12. 12. Lewis M, Tartaglia LA, Lee A, Bennet GL, Rice C, Wong GH, Chen EY, Goeddel DV (1991) Cloning and expression of cDNAs for two distinct murine tumour necrosis factor receptors demonstrate that one receptor is species specific. Proc Natl Acad Sci USA 88:2830-2834.
13. 13. Goodwin RG, Anderson D, Jerry R, Davis T, Brannan CI, Copeland NG, Jenkins NA, Smith CA (1991) Molecular cloning and expression of the type I and II murine receptors for tumour necrosis factor. Mol Cell Biol 11:3020-3026.
14. 14. Heller RA, Song K, Villaret D, Margolskee R, Dunne J, Hayakawa H, Ringold GM (1990) Amplified expression of tumour necrosis factor receptor in cells transfected with Epstein-Barr virus shuttle vector cDNA libraries. J Biol Chem 265:5708-5717.
15. 15. Heller RA, Song K, Onasch MA, Fischer WH, Chang D, Ringold GM (1990) Complementary DNA cloning of a receptor for tumour necrosis factor and demonstration of a shed form of the receptor. Proc Natl Acad Sci USA 87:6151-6155.
16. 16. Loetscher H, Pan Y-CE, Lahm H-W, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W (1990) Molecular cloning and expression of the human 55 kD tumour necrosis factor receptor. Cell 61:351-359.
17. 17. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GHW, Gatanaga T, Granger GA, Leutz R, Raab H, Kohr WJ, Goeddel DV (1990) Molecular cloning and expression of a receptor for human tumour necrosis factor. Cell 61:361-370.
18. 18. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG (1990) A receptor for tumour necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019-1023.
19. 19. Hohmann HP, Brockhaus M, Baeuerle PA, Remy R, Kolbeck R, van Loon APGM (1990) Expression of types A and B tumour necrosis factor (TNF) receptor is independently regulated, and both receptors mediate activation of the transcription factor NFκB. J Biol Chem 265:22409-22417.
20. 20. Aggarwal BB, Graff K, Samal B, Higuchi M, Liao W (1993) Regulation of two forms of the TNF receptors by phorbol ester and dibutyryl cyclic adenosine 3′, 5′-monophosphate in human histiocytic lymphoma cell line U-937. Lymphokine Cytokine Res 12:149-158.
21. 21. Espevik T, Brockhaus M, Loetscher H, Nostad U, Shalaby R (1990) Characterization of binding and biological effects of monoclonal antibodies against a human tumour necrosis factor receptor. J Exp Med 175:415-426.
22. 22. Engelmann H, Holtman H, Brakebusch C, Avin YS, Sarov I, Nophar Y, Hadas E, Leitner O, Wallach D (1990) Antibodies to a soluble form of a tumour necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem 265:14497-14504.
23. 23. Thoma B, Grell M, Pfizenmaier K, Scheurich P (1990) Identification of the 60 kD tumour necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J Exp Med 172:1019-1023
24. 24. Wong GHW, Tartaglia LA, Lee MS, Goeddel DV (1992) Antiviral activity of TNF is signalled through the 55 kD TNF type I receptor. J Immunol 149:3350-3353.
25. 25. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV (1991) The two different receptors for tumour necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88:9292-9296.
26. 26. Gehr G, Gentz R, Brockhaus M, Loetscher HR, Lesslauer W (1992) Both tumour necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J Immunol 149:911-917.
27. 27. Tartagli LA, Goeddel DV (1992) The two TNF receptors. Immunol Today 13:151-153.
28. 28. Tartaglia LA, Pennica D, Goeddel DV (1993) Ligand passing: the 75-kDa tumour necrosis factor (TNF) receptor recruits TNF for signalling by the 55-kDa TNF receptor. J Biol Chem 268:18542-18548.
29. 29. Higuchi M, Aggarwal BB (1993) p80 form of the human tumour necrosis factor is involved in DNA fragmentation. FEBS Lett 331:252-255.
30. 30. Grell M, Scheurich P, Meager A, Pfizenmaier K (1993) TR60 and TR80 tumour necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res 12:143-148.
31. 31. Bigda J, Beletsky I, Brakebusch C, Varfolomeev Y, Engelmann H, Bigda J, Holtmann H, Wallach D (1994) Dual role of the p75 tumour necrosis factor (TNF) receptor in TNF cytotoxicity. J Exp Med 180:445-460.
32. 32. Heller RA, Song K, Fan N, Chang DJ (1992) The p70 tumour necrosis factor receptor mediates cytotoxicity. Cell 70:47-56.
33. 33. Clement M, Stamenkovic I (1994) Fas and tumour necrosis factor receptor-mediated cell death: similarities and distinctions. J Exp Med 180:557-567.
34. 34. Engelmann H, Novick D, Wallach D (1990) Two tumour necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumour necrosis factor receptors. J Biol Chem 265:1531-1536.
35. 35. Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK, Squires CH, Thompson RC, Vannice JL (1990) A second tumour necrosis factor receptor gene product can shed a naturally occurring tumour necrosis factor inhibitor. Proc Natl Acad Sci USA 87:8331-8335.
36. 36. Heilig B, Wermann M, Gallati H, Brockhaus M, Berke B, Egen O, Pezzuto A, Hunstein W (1992) Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis. Clin Investigator 70:22-27.
37. 37. Ryffel B, Brockhaus M, Duermueller U, Gudat F (1991) Tumour necrosis factor receptors in lymphoid tissues and lymphomas. Am J Pathol 139:7-15.
38. 38. Aggarwal BB, Eessalu TE, Haas PE (1985) Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 318:665-667.
39. 39. Pandita R, Pocsik E, Aggarwal B (1992) Interferon-γ induces cell surface expression for both types of tumour necrosis factor receptors. FEBS Lett 312:87-90.
40. 40. Owen-Schaub LB, Crump WL, Morin GI, Grimm EA (1989) Regulation of lymphocyte tumour necrosis factor receptors by IL-2. J Immunol 143:2236-2241.
41. 41. Porteu F, Nathan C (1990) Shedding of tumour necrosis factor receptors by activated human neutrophils. J Exp Med 172:599-607.
42. 42. Winzen R, Wallach D, Kemper O, Resch K, Holtmann H (1993) Selective up-regulation of the 75-kDa tumour necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J Immunol 150:4346-4353.
43. 43. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB (1993) Soluble tumour necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151:1548-1561.
44. 44. Volpes R, van den Oord JJ, De Vos R, Desmet V (1992) Hepatic expression of type A and type B receptors for tumour necrosis factor. J Hepatol 14:361-369.
45. 45. Spinas GA, Keller U, Brockhaus M (1992) Release of soluble receptors for tumour necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinaemia. J Clin Invest 90:533-536.
46. 46. Higuchi M, Aggarwal BB (1994) TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J Immunol 152:3550-3558.
47. 47. Gonzálex-Amaro R, García-Monzón C, García-Buey L, Moreno Otero R, Alonso JL, Yagüe E, Pivel JP, Lopéz-Cabrera,. Fernández-Ruiz E, Sanchez-Madrid F (1994) Induction of tumour necrosis factor a production by human hepatocytes in chronic viral hepatitis. J Exp Med 179:841-848.
48. 48. Daniels HM, Meager A, Eddleston ALWF, Alexander GJM, Williams R (1990) Spontaneous production of tumour necrosis factor α and interleukin-1β during interferon-α treatment of chronic HBV infection. Lancet 335:875-877.
49. 49. Mathison JC, Wolfson E, Ulevitch RJ (1988) Participation of tumour necrosis in the mediation of Gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 1:1925-1937.
50. 50. Tiegs G, Wolter M, Wendel A (1989) Tumour necrosis factor is a terminal mediator in D-galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 38:627-631.
51. 51. Jones AL, Selby P (1989) Tumour necrosis factor: Clinical relevance. Cancer Surv 8:817-836.
52. 52. Leist M, Gantner F, Jilg S, Wendel A (1995) Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 154:1307-1316.